Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
icosapent ethyl (vascepa) (2 trials)
l-glutamine (1 trial)
Anemia, Sickle Cell (Phase 2)
Hypertriglyceridemia (Phase 3)
Trials (4 total)
Trial APIs (2 total)